Clincosm LogoSign in Get a demo

adenocarcinoma of the prostate

Showing 26 - 50 of 101
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer Trial in New Brunswick, Portland

Completed
Has Results
  • Adenocarcinoma of the Prostate
  • +3 more
  • ipilimumab
  • laboratory biomarker analysis
  • New Brunswick, New Jersey
  • +1 more
Sep 23, 2020

Adenocarcinoma of the Prostate, Bone Metastases, Hormone-resistant Prostate Cancer Trial in Duarte, Pasadena, Salt Lake City

Completed
Has Results
  • Adenocarcinoma of the Prostate
  • +5 more
  • sipuleucel-T
  • +2 more
  • Duarte, California
  • +2 more
Aug 21, 2020

Adenocarcinoma of the Prostate, Recurrent Prostate Cancer, Stage I Prostate Cancer Trial (brachytherapy, image-guided radiation

Withdrawn
  • Adenocarcinoma of the Prostate
  • +4 more
  • brachytherapy
  • +2 more
  • (no location specified)
Jul 23, 2020

Adenocarcinoma of the Prostate, Recurrent Prostate Cancer, Stage I Prostate Cancer Trial in Cleveland (radiation, procedure,

Completed
Has Results
  • Adenocarcinoma of the Prostate
  • +5 more
  • stereotactic body radiation therapy
  • +2 more
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
May 8, 2020

Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer Trial in Stanford (drug, radiation,

Completed
  • Adenocarcinoma of the Prostate
  • +5 more
  • sodium selenite
  • +4 more
  • Stanford, California
    Stanford University, School of Medicine
Feb 14, 2020

Adenocarcinoma of the Prostate Trial in Baltimore (18F-DCFPyL)

Completed
Has Results
  • Adenocarcinoma of the Prostate
  • Baltimore, Maryland
    SKCCC
Jan 22, 2020

Adenocarcinoma of the Prostate, Stage I Prostate Cancer, Stage II Prostate Cancer Trial in Houston (other, procedure, drug)

Completed
Has Results
  • Adenocarcinoma of the Prostate
  • +3 more
  • placebo
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 16, 2019

Adenocarcinoma of the Prostate, Recurrent Prostate Cancer, Stage I Prostate Cancer Trial in Chicago (dietary supplement, other,

Terminated
Has Results
  • Adenocarcinoma of the Prostate
  • +4 more
  • genistein
  • +2 more
  • Chicago, Illinois
    Northwestern University
Aug 27, 2019

Adenocarcinoma of the Prostate Trial in Los Angeles (NanoPac®)

Completed
Has Results
  • Adenocarcinoma of the Prostate
  • Los Angeles, California
    University of Southern California
Jul 29, 2019

Adenocarcinoma of the Prostate Trial in Sutton, London (Olaparib)

Unknown status
  • Adenocarcinoma of the Prostate
  • Sutton, Surrey, United Kingdom
  • +1 more
Aug 13, 2019

Prostate Cancer, Adenocarcinoma of the Prostate, Stage I Prostate Cancer Trial in Philadelphia (radiation therapy treatment

Completed
  • Prostate Cancer
  • +4 more
  • radiation therapy treatment planning/simulation
  • +4 more
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of The University of Pennsylvania
Jul 24, 2019

Adenocarcinoma of the Prostate Trial in Lisboa (radiation, procedure, device)

Unknown status
  • Adenocarcinoma of the Prostate
  • IGRT 45 Gy in 5 fractions of 9 Gy
  • +3 more
  • Lisboa, Portugal
    Champalimaud Foundation
Jul 22, 2019

Adenocarcinoma of the Prostate, Stage I Prostate Cancer, Stage II Prostate Cancer Trial in Richmond (intensity modulated

Completed
  • Adenocarcinoma of the Prostate
  • +4 more
  • intensity modulated external beam radiation therapy
  • Richmond, Virginia
  • +1 more
Jun 27, 2019

Adenocarcinoma of the Prostate Trial in Cleveland (enzalutamide)

Completed
Has Results
  • Adenocarcinoma of the Prostate
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Mar 11, 2019

Hormone-refractory Prostate Cancer, Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer Trial in United States

Completed
Has Results
  • Hormone-refractory Prostate Cancer
  • +4 more
  • Duarte, California
  • +5 more
Feb 5, 2019

Advanced Solid Tumors, Adenocarcinoma of the Prostate Trial in United States (Alisertib, Docetaxel)

Completed
Has Results
  • Advanced Solid Tumors
  • Adenocarcinoma of the Prostate
  • Indianapolis, Indiana
  • +3 more
Oct 4, 2018

Adenocarcinoma of the Prostate Trial in Salt Lake City (Pazopanib, Placebo)

Completed
Has Results
  • Adenocarcinoma of the Prostate
  • Salt Lake City, Utah
    Huntsman Cancer Institute
Dec 11, 2018

Adenocarcinoma of the Prostate, Castration-resistant Prostate Cancer, Recurrent Prostate Cancer Trial in Seattle (Cabozantinib)

Terminated
Has Results
  • Adenocarcinoma of the Prostate
  • +4 more
  • Seattle, Washington
    Seattle Cancer Care Alliance/University of Washington
Nov 6, 2018

Adenocarcinoma of the Prostate, Bone Metastases, Soft Tissue Metastases Trial in Aurora (Ranolazine)

Completed
Has Results
  • Adenocarcinoma of the Prostate
  • +6 more
  • Aurora, Colorado
    University of Colorado Cancer Center
Nov 29, 2018

Adenocarcinoma of the Prostate Trial in Portland (Cyclophosphamide, DRibble Vaccine, HPV Vaccinations)

Completed
  • Adenocarcinoma of the Prostate
  • Portland, Oregon
    Providence Health & Services
Oct 9, 2018

Adenocarcinoma of the Prostate Trial in Lausanne (Active surveillance)

Terminated
  • Adenocarcinoma of the Prostate
  • Active surveillance
  • Lausanne, Switzerland
    Centre Hospitalier Universitaire Vaudois (CHUV)
Sep 25, 2018

Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer Trial in United States (drug,

Completed
Has Results
  • Adenocarcinoma of the Prostate
  • +3 more
  • Hsp90 inhibitor STA-9090
  • +7 more
  • Baltimore, Maryland
  • +3 more
Aug 19, 2018

Adenocarcinoma of the Prostate, Stage IV Prostate Cancer Trial in Detroit, Houston, Madison (cediranib maleate, docetaxel,

Terminated
Has Results
  • Adenocarcinoma of the Prostate
  • Stage IV Prostate Cancer
  • cediranib maleate
  • +3 more
  • Detroit, Michigan
  • +3 more
Jul 13, 2018

Adenocarcinoma of the Prostate Trial in Sutton (AZD5363, Enzalutamide)

Unknown status
  • Adenocarcinoma of the Prostate
  • Sutton, Surrey, United Kingdom
    Royal Marsden Hospital
Aug 7, 2018

Adenocarcinoma of the Prostate, Recurrent Prostate Cancer, Stage I Prostate Cancer Trial in Detroit (bevacizumab, laboratory

Completed
Has Results
  • Adenocarcinoma of the Prostate
  • +5 more
  • bevacizumab
  • laboratory biomarker analysis
  • Detroit, Michigan
  • +1 more
Jul 1, 2018